The fact that hepatocyte-derived ECM from the liver, which is a common metastatic site for colon cancer, stimulates CRIPTO expression in highly metastatic colon cancer cell line KM12SM may indicate a selective advantage for CRIPTO-expressing colon cancer cells to metastasize to the liver [153,155]. Here, CRIPTO is linked to malignant colon neoplasm.